Workflow
Ares Capital(ARCC)
icon
Search documents
Want Another $500 in Annual Dividend Income? Invest $6,900 in These 3 High-Yield Stocks.
The Motley Fool· 2025-07-31 09:51
Group 1: Altria Group - Altria Group's shares have increased by approximately 15% over the past 12 months despite a decline in cigarette volumes, with Marlboro shipment volume dropping by 11.4% year over year in Q2 [4][5] - The company has experienced a slight revenue decline of 0.4% year over year, but margin expansion has led to a 4.4% increase in operating income [5] - Altria's oral tobacco product sales rose by 6% year over year, and the company may benefit from increased regulatory oversight of unauthorized nicotine products [6] - The stock offers a 6.7% yield, with a history of consistent dividend increases, marking the 59th payout raise in 55 years [7] Group 2: Healthpeak Properties - Healthpeak Properties is a REIT focused on outpatient medical buildings, laboratories, and retirement communities, offering a 6.9% dividend yield [8] - The company faced challenges due to decreased demand for lab space from biotech start-ups but has merged with Physician's Realty to enhance its portfolio [9] - In Q2, adjusted funds from operations (FFO) rose to $0.44 per share, supporting current dividend payments of $0.305 per share per quarter [10] Group 3: Ares Capital - Ares Capital is a business development company (BDC) that provides loans to businesses, reporting a 10.9% average yield on its debt securities [11] - The stock offers an 8.4% yield, with a stable quarterly payout since 2009, despite some variability in past extra dividend payments [12] - Ares Capital is externally managed by Ares Management, which has approximately $546 billion in assets under management, and has a low non-accrual loan rate of 1.2% [13][14]
Ares Capital Q2 Earnings Miss Estimates as Expenses Rise Y/Y
ZACKS· 2025-07-30 16:25
Key Takeaways Ares Capital Corporation's (ARCC) second-quarter 2025 core earnings of 50 cents per share missed the Zacks Consensus Estimate by a penny. The bottom line also reflected a decline of 18% from the prior-year quarter. The results were primarily hurt by a decline in total investment income and higher expenses. Nonetheless, the company's robust portfolio activities offered some support. The fair value of accruing debt and other income-producing securities was $24.8 billion. Ares Capital's Balance S ...
Ignore The Fed-Trump Drama, Invest With 10% Yields
Seeking Alpha· 2025-07-30 11:35
Group 1 - The article promotes a portfolio strategy that generates income without the need for selling assets, aiming to simplify retirement investing [1] - It emphasizes the importance of community and education in investing, suggesting that individuals should not invest alone [3] - The service offers features such as model portfolios, buy/sell alerts, and regular market updates to assist investors [3] Group 2 - There is a growing concern about media bias, as people tend to choose news outlets that align with their beliefs [2] - The article highlights the increasing number of news outlets available across various platforms, including print, online, and social media [2]
Billionaire Investor Sounds The All-Clear; We Think These Dividend Stocks Could Soar
Seeking Alpha· 2025-07-30 11:05
Group 1 - Billionaire investors Stephen Schwarzman and John Gray from Blackstone, the world's largest alternative asset manager, emphasized the restoration of confidence in the economy [1] - Blackstone currently manages $1.2 trillion in assets [1] Group 2 - The company invests significant resources, including thousands of hours and over $100,000 annually, into researching profitable investment opportunities [2] - The approach has garnered over 180 five-star reviews from satisfied members [2]
Ares Capital(ARCC) - 2025 Q2 - Earnings Call Transcript
2025-07-29 17:02
Financial Data and Key Metrics Changes - The company reported stable core earnings of $0.50 per share, consistent with the prior quarter, representing an annualized return on equity of 10% [9] - GAAP net income per share was $0.52 for the quarter, compared to $0.36 in the prior quarter and $0.52 in the same quarter last year [18] - The total portfolio at fair value increased to $27.9 billion from $27.1 billion at the end of the previous quarter and up from $25 billion a year ago [19][26] Business Line Data and Key Metrics Changes - The company originated over $2.5 billion of new investment commitments, with incumbent borrowers accounting for 74% of commitments [25] - Net fundings of $644 million were more than double the prior quarter's level, contributing to a 3% quarter-over-quarter increase in the overall size of the portfolio at fair value [26] - The weighted average LTM EBITDA growth of portfolio companies was 13%, up from 12% last quarter [28] Market Data and Key Metrics Changes - The second quarter saw a temporary slowdown in transaction activity due to policy-driven volatility, but activity began to normalize later in the quarter [10][11] - Nearly three-quarters of gross commitments were from incumbent relationships, indicating a stabilizing force in the market [11] - The company is seeing transaction activity recovering to pre-tariff levels, with a healthy backlog of $2.6 billion as of July 24, 2025 [29] Company Strategy and Development Direction - The company aims to maintain its position as a valuable partner in varying market conditions, focusing on expanding commitments with existing borrowers while also exploring new opportunities [12][15] - The strategy includes being active across lower, core, and upper middle markets, with a notable focus on larger borrowers amid market uncertainty [13][14] - The company emphasizes portfolio diversification to mitigate risks from negative credit events [26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to navigate evolving market conditions and capitalize on emerging opportunities, despite a modest uptick in non-accruals [16][29] - The company is optimistic about the potential for increased transaction activity in the second half of the year, supported by a growing number of opportunities reviewed [12][29] - Management noted that the health of the portfolio remains strong, with borrower leverage levels below the five-year average [16][28] Other Important Information - The company declared a third-quarter dividend of $0.48 per share, marking the sixteenth consecutive year of stable or increasing regular dividends [23] - The company has a significant amount of dry powder, with liquidity totaling nearly $6.5 billion, positioning it well for future investments [22] Q&A Session Summary Question: Can you talk about any improvement in terms spreads and upfront fees? - Management noted that while there was some volatility in terms, spreads have stabilized over the last few quarters, with a mix of activity seen in the market [33][34] Question: Can you discuss the off-balance sheet vehicles and their growth potential? - Management indicated that both vehicles are strategically important and may grow from current levels [36][37] Question: How are you balancing leverage versus issuing new equity? - Management emphasized the importance of maintaining flexibility and noted that current leverage levels provide room to capitalize on market opportunities [41][42] Question: Can you provide insights on the increase in non-accruals? - Management acknowledged a slight increase in non-accruals but stated that it is not indicative of broader economic trends, attributing it to idiosyncratic factors [46][49] Question: What is the impact of tariffs on portfolio companies? - Management reported improved sentiment regarding the ability of portfolio companies to mitigate tariff impacts, with exposure now at a low single-digit percentage [80][82]
Ares Capital(ARCC) - 2025 Q2 - Earnings Call Transcript
2025-07-29 17:00
Financial Data and Key Metrics Changes - The company reported stable core earnings of $0.50 per share, consistent with the prior quarter, representing an annualized return on equity of 10% [8] - GAAP net income per share was $0.52 for Q2 2025, compared to $0.36 in the prior quarter and $0.52 in Q2 2024 [17] - The total portfolio at fair value increased to $27.9 billion from $27.1 billion at the end of Q1 2025 and from $25 billion a year ago [18] Business Line Data and Key Metrics Changes - The company originated over $2.5 billion of new investment commitments, with incumbent borrowers accounting for 74% of commitments [24] - Net fundings were $644 million, more than double the prior quarter's level, contributing to a 3% quarter-over-quarter increase in the overall size of the portfolio at fair value [25] - The weighted average LTM EBITDA growth of portfolio companies was 13%, up from 12% last quarter [27] Market Data and Key Metrics Changes - The second quarter saw a temporary slowdown in transaction activity due to policy-driven volatility, but activity began to rebuild towards the end of the quarter [10] - The company noted that June accounted for nearly half of the quarter's transaction activity, indicating potential momentum for the second half of the year [13] - The backlog as of July 24, 2025, stood at $2.6 billion, with total commitments for Q3 to date at $1.1 billion [29] Company Strategy and Development Direction - The company aims to maintain its position as a valuable partner in varying market conditions, leveraging its broad portfolio and extensive market relationships [11] - The focus remains on expanding commitments with existing borrowers while also growing presence among non-sponsored borrowers in targeted industries [12] - The company is strategically positioned to provide capital to larger borrowers, as demonstrated by its role in the largest private credit LBO on record with Dun and Bradstreet [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to navigate evolving market conditions and capitalize on emerging opportunities, citing a resilient business model [16] - The company is optimistic about the normalization of transaction activity and the consistency of core earnings exceeding the dividend [29] - Management noted that the overall health of the portfolio remains strong, with borrower leverage levels below the five-year average [15] Other Important Information - The company has maintained stable or increasing regular quarterly dividends for 64 consecutive quarters, with a declared Q3 2025 dividend of $0.48 per share [22] - The company estimates a taxable income spillover of $878 million or $1.29 per share available for distribution to stockholders in 2025 [22] Q&A Session Summary Question: Can you talk about any improvement in terms spreads and upfront fees? - Management noted that while there was some volatility in terms, spreads have stabilized over the last several quarters, with a mix of activity seen in the market [33][34] Question: Can you discuss the ability to expand off-balance sheet vehicles like SDLP and Ivy Hill? - Management indicated that both vehicles are strategically important and may grow from current levels [36] Question: How are you balancing leverage versus issuing new equity? - Management emphasized the importance of maintaining flexibility and noted that current leverage levels provide room to capitalize on future opportunities [40][41] Question: Can you provide insight into the increase in non-accruals? - Management acknowledged a slight uptick in non-accruals but emphasized that these are idiosyncratic cases and not indicative of broader trends [46][48] Question: What is the impact of tariffs on portfolio companies? - Management reported improved sentiment regarding tariff impacts, with a reduction in high-risk names in the portfolio [80][82]
Ares Capital(ARCC) - 2025 Q2 - Earnings Call Presentation
2025-07-29 16:00
Financial Performance - GAAP Net Income Per Share for Q2 2025 was $052, matching Q2 2024, but up from $036 in Q1 2025[12] - Core EPS for Q2 2025 was $050, consistent with Q1 2025, but down from $061 in Q2 2024[12] - Net Investment Income Per Share for Q2 2025 was $049, down from $054 in Q1 2025 and $062 in Q2 2024[12] - Net Asset Value Per Share increased to $1990 in Q2 2025, compared to $1982 in Q1 2025 and $1961 in Q2 2024[12] - Investment income for the three months ended June 30, 2025, was $745 million, compared to $732 million for the three months ended March 31, 2025[23] Portfolio Composition and Activity - Total Fair Value of Investments reached $27886 million in Q2 2025, up from $27130 million in Q1 2025 and $24973 million in Q2 2024[13] - Gross Commitments were $2573 million in Q2 2025, lower than $3453 million in Q1 2025 and $3857 million in Q2 2024[13] - Exits of Commitments were $1963 million in Q2 2025, compared to $2857 million in Q1 2025 and $1376 million in Q2 2024[13] - First Lien Senior Secured Loans constituted 59% of the portfolio at fair value as of June 30, 2025[19] - As of July 24, 2025, Ares Capital had a backlog of approximately $26 billion[68]
Ares Capital (ARCC) Reports Q2 Earnings: What Key Metrics Have to Say
ZACKS· 2025-07-29 14:31
Ares Capital (ARCC) reported $745 million in revenue for the quarter ended June 2025, representing a year- over-year decline of 1.3%. EPS of $0.50 for the same period compares to $0.61 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $746.71 million, representing a surprise of -0.23%. The company delivered an EPS surprise of -1.96%, with the consensus EPS estimate being $0.51. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...
Ares Capital (ARCC) Q2 Earnings and Revenues Miss Estimates
ZACKS· 2025-07-29 12:26
Ares Capital (ARCC) came out with quarterly earnings of $0.5 per share, missing the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.61 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -1.96%. A quarter ago, it was expected that this private equity firm would post earnings of $0.54 per share when it actually produced earnings of $0.5, delivering a surprise of -7.41%. Empirical research shows a stron ...
Ares Capital(ARCC) - 2025 Q2 - Quarterly Report
2025-07-29 01:23
[Part I. Financial Information](index=3&type=section&id=Part%20I.%20Financial%20Information) [Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) The financial statements present Ares Capital Corporation's financial position as of June 30, 2025, with total assets of **$29.1 billion** and a six-month net increase in stockholders' equity of **$602 million** [Consolidated Balance Sheet](index=3&type=section&id=Consolidated%20Balance%20Sheet) Consolidated Balance Sheet Summary (in millions) | Account | June 30, 2025 (unaudited) | December 31, 2024 | | :--- | :--- | :--- | | **Assets** | | | | Total investments at fair value | $27,886 | $26,720 | | Cash and cash equivalents | $447 | $635 | | **Total assets** | **$29,071** | **$28,254** | | **Liabilities** | | | | Debt | $14,109 | $13,727 | | **Total liabilities** | **$15,037** | **$14,899** | | **Stockholders' Equity** | | | | **Total stockholders' equity** | **$14,034** | **$13,355** | | **NET ASSETS PER SHARE** | **$19.90** | **$19.89** | [Consolidated Statement of Operations](index=4&type=section&id=Consolidated%20Statement%20of%20Operations) Statement of Operations Summary (in millions, except per share data) | Metric | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2024 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | :--- | :--- | | **Total investment income** | **$745** | **$755** | **$1,477** | **$1,456** | | Total expenses | $395 | $356 | $755 | $725 | | **Net investment income** | **$342** | **$386** | **$707** | **$712** | | Net realized and unrealized gains (losses) | $19 | $(64) | $(105) | $73 | | **Net increase in stockholders' equity** | **$361** | **$322** | **$602** | **$771** | | **Basic and diluted net income per share** | **$0.52** | **$0.52** | **$0.88** | **$1.28** | [Consolidated Schedule of Investments](index=5&type=section&id=Consolidated%20Schedule%20of%20Investments) - As of June 30, 2025, total investments at fair value were **$27.89 billion**, with an amortized cost of **$27.58 billion**[140](index=140&type=chunk) Portfolio Composition by Industry (as of June 30, 2025) | Industry | % of Portfolio (Fair Value) | | :--- | :--- | | Software and Services | 23.5% | | Health Care Equipment and Services | 12.9% | | Financial Services | 10.2% | | Commercial and Professional Services | 9.9% | | Insurance | 6.4% | | Other | 37.1% | | **Total** | **100.0%** | [Consolidated Statement of Stockholders' Equity](index=153&type=section&id=Consolidated%20Statement%20of%20Stockholders'%20Equity) - Total stockholders' equity increased from **$13.36 billion** at December 31, 2024, to **$14.03 billion** at June 30, 2025. This increase was driven by net proceeds from stock issuances (**$702 million**) and net income (**$602 million**), partially offset by dividends declared (**$665 million**)[310](index=310&type=chunk) [Consolidated Statement of Cash Flows](index=154&type=section&id=Consolidated%20Statement%20of%20Cash%20Flows) Cash Flow Summary for the Six Months Ended June 30 (in millions) | Cash Flow Activity | 2025 | 2024 | | :--- | :--- | :--- | | Net cash used in operating activities | $(517) | $(1,339) | | Net cash provided by financing activities | $321 | $1,456 | | **Change in cash, cash equivalents and restricted cash** | **$(196)** | **$117** | [Notes to Consolidated Financial Statements](index=155&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) - The company's investment objective is to generate both current income and capital appreciation, primarily through first and second lien senior secured loans. It is externally managed by Ares Capital Management LLC[317](index=317&type=chunk)[318](index=318&type=chunk) - Substantially all investments are valued at fair value in good faith by the Valuation Designee (the investment adviser), using techniques like enterprise value (EV) and yield analysis, with input from independent third-party valuation providers[328](index=328&type=chunk)[329](index=329&type=chunk)[481](index=481&type=chunk) - As of June 30, 2025, the company had total debt of **$14.1 billion** with an asset coverage ratio of **199%**, which is above the required **150%**[408](index=408&type=chunk)[409](index=409&type=chunk) - Subsequent to the quarter end, in July 2025, the company increased commitments under its Revolving Credit Facility, Revolving Funding Facility, and SMBC Funding Facility, and repaid its July 2025 Notes upon maturity[531](index=531&type=chunk)[532](index=532&type=chunk)[534](index=534&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=198&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the company's financial performance, including **$2.6 billion** in new investment commitments for Q2 2025 and net investment income of **$342 million** [Overview](index=199&type=section&id=Overview) - Ares Capital's investment objective is to generate both current income and capital appreciation through debt and equity investments, primarily in first and second lien senior secured loans[541](index=541&type=chunk) - Since its IPO in 2004 through June 30, 2025, the company's exited investments have generated a gross internal rate of return of approximately **13%**[543](index=543&type=chunk) - Over the same period, realized gains have exceeded realized losses by approximately **$0.9 billion**, with an average annualized net realized gain rate of about **0.8%**[544](index=544&type=chunk)[546](index=546&type=chunk) [Portfolio and Investment Activity](index=201&type=section&id=Portfolio%20and%20Investment%20Activity) Investment Activity for the Three Months Ended June 30 (in millions) | Activity | 2025 | 2024 | | :--- | :--- | :--- | | Total new investment commitments | $2,573 | $3,857 | | Principal amount of investments funded | $2,735 | $3,277 | | Principal amount of investments sold or repaid | $2,091 | $1,507 | Portfolio Composition by Investment Type (as of June 30, 2025) | Investment Type | Fair Value (in millions) | % of Total | | :--- | :--- | :--- | | First lien senior secured loans | $16,547 | 59.3% | | Second lien senior secured loans | $1,523 | 5.5% | | Subordinated certificates of the SDLP | $1,052 | 3.8% | | Senior subordinated loans | $1,388 | 5.0% | | Preferred equity | $2,642 | 9.5% | | Ivy Hill Asset Management, L.P. | $2,081 | 7.4% | | Other equity | $2,653 | 9.5% | | **Total** | **$27,886** | **100.0%** | - As of June 30, 2025, the weighted average grade of the investment portfolio at fair value was **3.1**, with **95.5%** of the portfolio rated in the top two categories (Grades 3 and 4)[562](index=562&type=chunk) - Loans on non-accrual status represented **1.2%** of the total portfolio at fair value as of June 30, 2025, an increase from **1.0%** as of December 31, 2024[563](index=563&type=chunk) [Results of Operations](index=215&type=section&id=Results%20of%20Operations) Operating Results Summary (in millions) | Metric | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2024 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | :--- | :--- | | Total investment income | $745 | $755 | $1,477 | $1,456 | | Total expenses | $395 | $356 | $755 | $725 | | **Net investment income** | **$342** | **$386** | **$707** | **$712** | | **Net increase in stockholders' equity** | **$361** | **$322** | **$602** | **$771** | - Interest income for Q2 2025 decreased slightly from Q2 2024 due to declining base rates, partially offset by a larger average portfolio size. For the six-month period, interest income increased due to the larger portfolio[602](index=602&type=chunk) - Interest and credit facility fees increased to **$188 million** for Q2 2025 from **$174 million** in Q2 2024, primarily due to a higher average principal amount of outstanding debt[608](index=608&type=chunk)[609](index=609&type=chunk) - For Q2 2025, the company recognized net realized gains of **$117 million** on investments and net unrealized losses of **$43 million**[621](index=621&type=chunk)[627](index=627&type=chunk) [Financial Condition, Liquidity and Capital Resources](index=223&type=section&id=Financial%20Condition%2C%20Liquidity%20and%20Capital%20Resources) - As of June 30, 2025, the company had **$14.1 billion** in outstanding debt and an asset coverage ratio of **199%**, exceeding the regulatory requirement of **150%**[632](index=632&type=chunk) - During the six months ended June 30, 2025, the company raised net proceeds of **$701.9 million** from "at the market" offerings of **32.0 million** shares[634](index=634&type=chunk) - The stock repurchase program, authorizing up to **$1.0 billion** in repurchases, was extended to February 15, 2026. No shares were repurchased during the first six months of 2025[638](index=638&type=chunk)[639](index=639&type=chunk) - From July 1 to July 24, 2025, the company made new investment commitments of approximately **$1.1 billion** and had an investment backlog of approximately **$2.6 billion**[675](index=675&type=chunk)[677](index=677&type=chunk) [Critical Accounting Estimates](index=231&type=section&id=Critical%20Accounting%20Estimates) - The most critical accounting estimate is the valuation of portfolio investments, as most do not have readily available market values[679](index=679&type=chunk)[684](index=684&type=chunk) - The valuation process is conducted quarterly by the investment adviser (as Valuation Designee) and involves a multi-step process, including input from independent third-party valuation providers and review by a valuation committee[682](index=682&type=chunk)[687](index=687&type=chunk) - Primary valuation techniques for Level 3 assets include enterprise value (EV) analysis (using EBITDA multiples or discounted cash flow) and yield analysis for debt investments[689](index=689&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=234&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company's primary market risks are investment valuation and interest rate fluctuations, with **69%** of the portfolio in variable-rate investments as of June 30, 2025 - The company's primary market risks are changes in interest rates and the valuations of its investment portfolio, which are inherently uncertain due to the lack of a ready market for most investments[692](index=692&type=chunk)[693](index=693&type=chunk) - As of June 30, 2025, **69%** of the investment portfolio at fair value consisted of variable-rate investments. The company utilizes interest rate swaps to manage its exposure on certain fixed-rate liabilities[696](index=696&type=chunk) Annualized Impact on Net Income from Interest Rate Changes (in millions) | Basis Point Change | Net Income Change | | :--- | :--- | | Up 300 basis points | $334 | | Up 200 basis points | $223 | | Up 100 basis points | $111 | | Down 100 basis points | $(121) | | Down 200 basis points | $(242) | | Down 300 basis points | $(354) | [Controls and Procedures](index=235&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of June 30, 2025, with no material changes to internal control over financial reporting - Management concluded that the company's disclosure controls and procedures were effective at a reasonable assurance level as of June 30, 2025[700](index=700&type=chunk) - No material changes to the company's internal control over financial reporting occurred during the quarter ended June 30, 2025[701](index=701&type=chunk) [Part II. Other Information](index=235&type=section&id=Part%20II.%20Other%20Information) [Legal Proceedings](index=235&type=section&id=Item%201.%20Legal%20Proceedings) The company and its affiliates are subject to legal proceedings and regulatory inquiries in the ordinary course of business - The company, its officers, and its investment adviser are subject to legal proceedings from time to time arising from their investments and operations[702](index=702&type=chunk) [Risk Factors](index=236&type=section&id=Item%201A.%20Risk%20Factors) No material changes to the risk factors previously disclosed in the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 - The report refers investors to the risk factors described in the Annual Report on Form 10-K for the fiscal year ended December 31, 2024, for a comprehensive understanding of potential risks[705](index=705&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=236&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) No unregistered sales of equity securities occurred during the quarter, and the **$1.0 billion** stock repurchase program remains fully available - No equity securities were sold during the period in unregistered transactions[706](index=706&type=chunk) - The company's stock repurchase program, authorizing up to **$1.0 billion** in repurchases, was extended to February 15, 2026. No shares were repurchased in the quarter ended June 30, 2025, leaving the full **$1.0 billion** available[708](index=708&type=chunk)[709](index=709&type=chunk) [Defaults Upon Senior Securities](index=236&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) No defaults upon senior securities occurred during the reporting period - Not applicable[710](index=710&type=chunk) [Mine Safety Disclosures](index=236&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This disclosure item is not applicable to the company's operations - Not applicable[711](index=711&type=chunk) [Other Information](index=236&type=section&id=Item%205.%20Other%20Information) No directors or executive officers adopted or terminated Rule 10b5-1 trading plans during the quarter ended June 30, 2025 - No directors or executive officers adopted or terminated any Rule 10b5-1 trading plans or non-Rule 10b5-1 trading arrangements during the fiscal quarter[712](index=712&type=chunk) [Exhibits](index=238&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including credit agreement amendments and required certifications - The report includes several exhibits, such as amendments to credit facilities and certifications required under the Sarbanes-Oxley Act[717](index=717&type=chunk)